Welcome note

Welcome to this issue of Int. J. of Cancer and Biomedical Research (IJCBR). I hope that researchers, oncologists, laboratory workers, and science enthusiasts find our journal as an excellent source of sharing knowledge and resourceful information related to the cancer and biomedical research. Our vision is to create a high-quality publication that will be relevant, challenging, thought provoking, and inclusive of a diverse range of voices and perspectives, including graduate students, academic researchers and scholars, policy-makers through publishing original research articles, theoretical contributions, reviews of the literature, critical commentaries, case studies, book reviews. In the current issue, the readers will find high quality research articles in different aspects, including HCV, lupus nephritis, immunological efficiency of melanin, antitumor activities of fungi as well as different topic in cancer research, hepatocellular, laryngeal squamous cell carcinoma, lymphoma, endometrial carcinoma, and ascites carcinoma. These topics decipher certain cellular and molecular hallmarks of cancer in different organs. The overall finding of these studies open new avenues for future studies that can lead to exploring new biomarkers and treatment modalities.
We do believe that COVID-19 has fundamentally disrupted the practice of oncology, shifting care onto virtual platforms, rearranging the logistics and economics of running a successful clinical practice and research, and in some contexts, redefining what treatments patients with cancer should and can receive.